| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/12/2026 | ±2.2% | -0.1% | over-priced |
| 05/13/2026 | ±2.4% | +1.1% | over-priced |
| 02/25/2026 | ±2.5% | +0.2% | over-priced |
| 11/12/2025 | ±2.4% | +3.0% | under-priced |
| 08/13/2025 | ±2.4% | +3.1% | under-priced |
| 05/14/2025 | ±3.2% | -1.6% | over-priced |
| 02/27/2025 | ±3.3% | +0.2% | over-priced |
| 11/06/2024 | ±2.5% | +16.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $5.04 | $10.4B | $1.2B |
| Q1 FY2026 | $3.23 | $9.5B | $743M |
| Q4 FY2025 | — | $7.7B | $378M |
| Q3 FY2025 | $2.63 | $8.5B | $607M |
NUE (NUE) reports in 15 days, with the next report estimated for 11/11/2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 3.1% on average — the market has been roughly fair on NUE's earnings risk. Fundamentals into the print: EPS up 93.8% year-over-year, revenue up 23.0%. QuantLogix's live 5-factor engine currently reads NUE as a buy at 65/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →